QualityStocks News - Zenosense (ZENO) Commences New Company Website

QualityStocks would like to highlight Zenosense, Inc. (OTCQB: ZENO). The company is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.

In the company’s news,

Zenosense announced the launch of a new company website. Based in Valencia, Spain, Zenosense is a healthcare technology company engaging in the development and marketing of a detection device for use in hospitals and other healthcare settings. Zenosense’s device is being engineered to focus on detection of the Methicillin-resistant Staphylococcus aureus (MRSA) “Super-Bug”.

The new company website includes comprehensive details about Zenosense’s MRSA-detection device and its initiatives in its development, challenges for healthcare providers created by MRSA, and the device’s development team. SEC regulatory filings, news releases, stock performance, and other company-related information can be accessed there as well.

Zenosense looks to develop, market, and sell an effective MRSA detector, driven by the sizable costs associated with late detection of MRSA. The company seeks to provide a cost-efficient way for detecting MRSA in clinical settings, by route of in-licensed technology. Based on the costly consequences of late detection of MRSA, Zenosense believes that it has found a valuable new market segment for an effective, wearable detection device.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net  

To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage

To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks

Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net   

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.